🇺🇸 FDA
Patent

US 11512312

Treatment of Fuchs' endothelial corneal dystrophy

granted A61KA61K31/12A61K31/7088

Quick answer

US patent 11512312 (Treatment of Fuchs' endothelial corneal dystrophy) held by The Board of Regents of the University of Texas System expires Mon Nov 24 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Nov 29 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 24 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
22
CPC classes
A61K, A61K31/12, A61K31/7088, A61K31/7105, A61K31/713